A Phase IV multicentric, randomized, comparative clinical trial to assess the immunogenicity and Reactogenicity of two different lots of DTwP-HB+Hib (Pentavac) vaccine manufactured by Serum Institute Of India Ltd., Pune in Indian infants.
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Pharmacodynamics
- 23 Jan 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 05 Jun 2010 New trial record